Hamps Bio Reports Turnaround In H1 FY27 With Strong Growth
Hamps Bio Ltd · Financial Result · 07 Nov 2026, 1:40 am
Hamps Bio Reports Turnaround In H1 FY27 With Strong Growth Hamps Bio reported consolidated revenue from operations of ₹730.76 lakhs for the half year ended 30th Sep'26, up 83.1% YoY from ₹399.15 lakhs. Profit after tax turned around to ₹20.44 lakhs versus a net loss of ₹19.55 lakhs in the previous corresponding period, yielding a basic and diluted EPS of ₹0.23. The freeze-dried products segment drove top-line performance with ₹552.86 lakhs in revenue. Additionally, the company confirmed complete utilization of its ₹622.20 lakh IPO proceeds as of 31st Mar'26.
Original exchange filing (PDF)
More announcements from Hamps Bio Ltd
- Board meeting outcome for approval of Unaudited Financial Result for the half year ended 30.09.2026 · 07 Nov 2026
- Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Standalone And Consolidated .... · 06 Nov 2026
- The voting results along with the Scrutinizer report for 19th AGM is attached herewith. · 11 Sept 2026
- Board Meeting Outcome for Board Meeting held on 9th September, 2026. · 09 Sept 2026
- The proceedings of 19th AGM is attached herewith. · 09 Sept 2026
- We have attached herewith the annual report for the financial year 2025-26. · 18 Aug 2026
- We have attached herewith the Annual General Meeting notice for the year 2025-26. · 18 Aug 2026
- Outcome of Board Meeting. · 13 Aug 2026
